Clara cell 10-KDA protein inhibits endotoxin-induced airway contraction in isolated perfused rat lungs

Experimental Lung Research

Volumn 29, Issue 7, 2003, Pages 455-473

  Nosratabadi, Ali Reza ^a   Ljungman, Anders G ^a   Lindahl, Mats ^a   Welch, Richard ^b   Pilon, Aprile ^b   Tagesson, Christer ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Claragen Inc   (United States)

Author keywords

Asthma; CC10; CC16; Clara cell secretory protein; Isolated perfused rat lungs (IPRLs); Phospholipase A2 inhibitors; Uteroglobin

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; ICOSANOID; INTERLEUKIN 1BETA; INTERLEUKIN 6; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHOLIPASE A2 INHIBITOR; PROTEIN INHIBITOR; RUTOSIDE; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY; ANIMAL EXPERIMENT; ARTICLE; CLARA CELL; CONTROLLED STUDY; CYTOKINE RELEASE; INHIBITION KINETICS; LUNG; LUNG LAVAGE; LUNG PERFUSION; MALE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ACETYLCHOLINE; AIRWAY RESISTANCE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; LIPOPOLYSACCHARIDES; LUNG; MALE; NG-NITROARGININE METHYL ESTER; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RUTIN; UTEROGLOBIN;

EID: 0141959015     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140303778     Document Type: Article

References (46)

1. Bernard A, Dumont X, Roels H, Lauwerys R, Dierynck I, De Ley M, Stroobant V, Hoffmann E: The molecular mass and concentrations of protein 1 or Clara cell protein in biological fluids: a reappraisal. Clin Chim Acta. 1993;223:189-191.
2. Singh G, Katyal SL: Clara cell proteins. Ann N YAcad Sci. 2000;923:43-58.
3. Broeckaert F, Bernard A: Clara cell secretory protein (CC16): characteristics and perspectives as a lung peripheral biomarker. Clin Exp Allergy. 2000;30:469-475.
4. Bernard A, Marchandise FX, Depelchin S, Lauwerys R, Sibille Y: Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J. 1992;5:1231-1238.
5. Lindahl M, Ståhlbom B, Svartz J, Tagesson C: Protein patterns of human nasal and bronchoalveolar lavage fluids analyzed with two-dimensional gel electrophoresis. Electrophoresis. 1998;19:3222-3229.
6. Miele L: Antiflammins: Bioactive peptides derived from uteroglobin. Ann N Y Acad Sci. 2000;923:129-140.
7. Arsalane K, Broeckaert F, Knoops B, Wiedig M, Toubeau G, Bernard A: Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopolysaccharide administration. Am J Respir Crit Care Med. 2000;161:1624-1630.
8. Hermans C, Knoops B, Wiedig M, Arsalane K, Toubeau G, Falmagne P, Bernard A: Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J. 1999;13:1014-1021.
9. Laing IA, Goldblatt J, Eber E, Hayden CM, Rye PJ, Gibson NA, Palmer LJ, Burton PR, Le Souef PN: A polymorphism of the CC16 gene is associated with an increased risk of asthma. J Med Genet. 1998;35:465-467.
10. Laing IA, Hermans C, Bernard A, Burton PR, Goldblatt J, Le Souef PN: Association between plasma CC16 levels, the A38G polymorphism, and asthma. Am J Respir Crit Care Med. 2000;161:124-127.
11. Lensmar C, Nord M, Gudmundsson GH, Roquet A, Andersson O, Jornvall H, Eklund A, Grunewald J, Agerberth B: Decreased pulmonary levels of the anti-inflammatory Clara cell 16 kDa protein after induction of airway inflammation in asthmatics. Cell Mol Life Sci. 2000;57:976-981.
12. Shijubo N, Itoh Y, Yamaguchi T, Sugaya F, Hirasawa M, Yamada T, Kawai T, Abe S: Serum levels of Clara Cell 10-kDa protein are decreased in patients with asthma. Lung. 1999;177(1):45-52.
13. Lindahl M, Svartz J, Tagesson C: Demonstration of different forms of the anti-inflammatory proteins lipocortin-1 and Clara cell protein-16 in human nasal and bronchoalvolar lavage fluids. Electrophoresis. 1999;20:881-890.
14. 2 inhibitor, in acute lung injury. Eur Respir J. 1995;8:1647-1653.
15. 2-mediated inhibition of fibroblasts migration in vitro. Am J Respir Crit Care Med. 1995;152:290-297.
16. 2 inhibitory activity. Ann N Y Acad Sci. 2000;923:307-311.
17. 2 enzymes: classification and characterization. Biochim Biophys Acta. 2000;1488:1-19.
18. 2 family of enzymes in human nasal mucosa. Eur Respir J. 2001;18:130-138.
19. Aarsman AJ, Neys FW, van der Helm HA, Kuypers FA, van den Bosch H: Sera from patients suffering from inflammatory diseases contain IIA but not group V phospholipase A(2). Biochim Biophys Acta. 2000;1502:257-263.
20. 2 in patients with septic shock and trauma. Intensive Care Med. 1994;20:555-561.
21. Serhan CN, Haeggström JZ, Leslie CC: Lipid mediator networks in cell signalling: update and impact of cytokines. FASEB J. 1996;10:1147-1158.
22. 2 mediates nitric oxide production by alveolar macrophages and acute lung injury in pancreatitis. Ann Surg 1999;229:385-392.
23. Barnes PJ, Chung KF, Page CP: Inflammatory mediators of asthma: an update. Pharmacol. Rev. 1998;50:514-596.
24. 2 as defined by gene knockouts. Biochim Biophys Acta. 2000;1488:139-148.
25. Calabrese C, Triggiani M, Marone G, Mazzarella G: Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma. Allergy. 2000;55:27-30.
26. Uhlig S, Brasch F, Wollin L, Fehrenbach H, Richter J, Wendel A: Function and fine structural changes in isolated rat lungs challenged with endotoxin ex vivo and in vitro. Am J Pathol. 1995;146:1235-1247.
27. Ermert L, Ermert M, Merkle M, Goppelt-Struebe M, Duncker H-R, Grimminger F, Seeger W: Rat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge. Differential regulation in the various types of cells in the lung. Am J Pathol. 2000;156:1275-1287.
28. Baker DG, Toth BR, Goad ME, Barker SA, Means JC: Establishment and validation of an isolated rat lung model for pulmonary metabolism studies. J Appl Toxicol. 1999;19:83-91.
29. Amann R, Schuligoi R, Peskar BA: Eicosanoid release in the endotoxin-primed isolated perfused rat lung and its pharmacological modification. Inflamm Res. 1999;48:632-636.
30. Lindahl M, Ljungman AG, Bruhn R, Hede R, Tagesson C: Calcium ionophore-activated neutrophils prestimulated with endotoxin increase pulmonary arterial perssure and vascular leakage in isolated perfused rat lungs: role of platelet-activating factor. Exp Lung Res. 1991;17:77-89.
31. Uhlig S, Nüsing R, von Bethmann A, Featherstone RL, Klein, Brasch T, Müller K-M, Ullrich V, Wendel A: Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. Mol Med. 1996;2:373-383.
32. 2 in rat lung in vivo and in isolated perfused lungs. Am J Physiol. 1996;270:L752-L760.
33. Uhlig S, Wollin L: An improved set-up for the isolated rat lung. J Phamacol Toxicol Methods. 1994;31:85-94.
34. 2 activity. Life Sci. 1986;38:1813-1819.
35. Leyton J, Manyak MJ, Mukherjee AB, Miele L, Mantile G, Patierno SR: Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblast-conditioned medium. Cancer Res. 1994;54:3696-3699.
36. Ghafouri B, Ståhlbom B, Tagesson C, Lindahl M: Newly identified proteins in human nasal lavage fluid from non-smokers and smokers using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics. 2002;2:112-120.
37. Vasanthakumar G, Manjunath R, Mukherjee AB, Warabi H, Schiffmann E: Inhibition of phagocyte chemotaxis by uteroglobin, and inhibitor of blastocyst rejection. Biochem Pharmacol. 1988;37:389-394.
38. Hayashida S, Harrod KS, Whitsett JA: Regulation and function of CCSP during pulmonary Pseudomonas aeruginosa infection in vivo. Am J Physiol Lung Cell Mol Physiol. 2000;279:L452-459.
39. Dierynck I, Bernard A, Roels H, De Ley M: Potent inhibition of both human interferon-γ production and biologic activity by the Clara cell protein CC16. Am J Respir Cell Mol Biol. 1995;12:205-210.
40. Dierynck I, Bernard A, Roels H, De Ley M: The human Clara cell protein: biochemical and biological characterization of a natural immunosuppressor. Multiple Schlerosis. 1996;1:385-387.
41. Nomori H, Horio H, Kobayashi R, Morinaga S, Hirabayashi Y: Protein 1 (Clara cell protein) serum levels in healthy subjects and patients with bacterial pneumonia. Am J Respir Crit Care Med. 1995;152:746-750.
42. Ramsay PL, DeMayo FJ, Hegemier SE, Wearden ME, Smith CV, Welty SE: Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;164:155-161.
43. 2 and inducible NO-synthase in rat renal mesangial cells. Br J Pharmacol. 1999;127(1):51.
44. 2-potentiated inducible nitric oxide synthase expression by macrophages requires NF-κB activation. J Immunol. 2000;164:6359-6365.
45. Kim H, Lee HS, Chang KT, Ko TH, Baek KJ, Kwon NS: Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-κB. J Immunol. 1995;154(9):4741.
46. Heitmeier MR, Scarim AL, Corbett JA: Double-stranded RNA-induced inducible nitric oxide synthase expression and interleukin-1 release by murine macrophages requires NF-κB activation. J Biol Chem. 1998;273:15301.